• How is comprehensive genomic profiling different from single-gene ("hot spot") testing for solid tumors?

    Single-gene testing identifies only one or two classes of genomic alterations. Comprehensive genomic profiling (CGP) approach identifies four classes of genomic alterations: base substitutions, insertions and deletions/indels, copy number alterations, and rearrangements.

  • Who is eligible for the tests?

    Any patient with a solid tumor, hematologic malignancy, or sarcoma is eligible for our tests.

  • Whom can I contact with additional questions?

    Client Services

    Phone: 888.988.3639

    Fax: 617.418.2290

    Email: client.services@foundationmedicine.com

If you have a question that isn't answered above, you can also contact us using the form below and we'll follow up by email in 1-2 days